SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS
SMS Pharmaceuticals Ltd
-(SMSPHARMA)
XNSE:SMSPHARMA, XBOM:SMSPHARMA
SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri -- Executive Director Unidentified Speaker -- Analysts: Viraj
SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/G2_d7tTye3s Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked about the
SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna -- Executed Director LakshminarayanaTammineedi -- Chief
SMS Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from SMS Pharmaceuticals Ltd (SMSPHARMA) Q4 FY22 Earnings Concall Management Update: SMSPHARMA said its near-term focus remains on scaling up